Investor

Dugan Winkie, head of commercial strategy at Cedar, discusses the revenue cycle management-focused company and how it works with strategic partners to ensure payments are satisfied using conversational AI and empathetic communication.

Maite Malet, Asabys Partners director of investments and corporate development, discusses the Barcelona-based firm’s €180 million ($200 million) raise and its plans invest in 12 to 15 health tech companies to expand from the EU to the U.S.

The employer-focused hybrid care provider will use the funds to scale its operations and expand access to its preventative care model. 

The company will use the funds to scale its operations and further develop its technology as it aims to establish gait monitoring as a mainstream tool.

The company's Synapsis AI platform automates complex data readings, which allows for more efficient and optimal clinical research.

The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.

The message-based platform allows patients to get answers to complex medical questions, receive second opinions, seek urgent care and obtain assistance with end-of-life decisions.

The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.

The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.

The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.